WallStreetZenWallStreetZen

AnalystsSeamus Fernandez
Seamus Fernandez's Stock Forecasts

Analyst Ranking
Bottom 12%
#3660 out of 4126 analysts
Average Return
-8.79%
Win Rate
43%9 out of 21
Risk vs Reward
Poor
Good

Seamus Fernandez's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Tesaro IncTSRO
+97.51%$37.31$73.69
2018-09-24 -
2018-12-04
Buy
Hillevax IncHLVX
+88.43%$10.11$19.05
2022-05-23 -
2022-12-02
Strong Buy
Albireo Pharma IncALBO
+30.44%$18.23$23.78
2022-09-07 -
2022-12-02
Strong Buy
Merck & Co IncMRK
+21.62%$90.48$110.04
2022-10-09 -
2022-12-02
Strong Buy
Novo Nordisk A SNVO
+14.95%$110.40$126.90
2022-05-30 -
2022-12-02
Strong Buy

Seamus Fernandez's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dice Therapeutics IncDICE
1Strong Buy$65.00+78.18%Initiates Coverage On
18 days ago
Merck & Co IncMRK
6Strong Buy$111.00+0.87%Maintains
a month ago
Bristol Myers Squibb CoBMY
5HoldN/AN/ADowngrades
2 months ago
Altimmune IncALT
2Strong Buy$26.00+130.50%Maintains
3 months ago
Albireo Pharma IncALBO
1Strong Buy$55.00+131.29%Initiates Coverage On
3 months ago
Novo Nordisk A SNVO
2Strong BuyN/AN/AUpgrades
6 months ago
Hillevax IncHLVX
1Strong Buy$40.00+109.97%Initiates Coverage On
6 months ago
Invivyd IncIVVD
2HoldN/AN/ADowngrades
a year ago
Novartis AgNVS
3HoldN/AN/ADowngrades
3 years ago
Dermira IncDERM2
1HoldN/AN/ADowngrades
3 years ago
Tesaro IncTSRO
4Hold$75.00N/ADowngrades
4 years ago
Intra Cellular Therapies IncITCI
3Buy$27.00N/AInitiates Coverage On
4 years ago
Allergan PLCAGN
3Buy$220.00N/AInitiates Coverage On
4 years ago
Aclaris Therapeutics IncACRS
1Buy$54.00N/AMaintains
5 years ago
Celldex Therapeutics IncCLDX
1Hold$3.00N/AMaintains
5 years ago
Astrazeneca PLCAZN
3Hold$38.00N/AMaintains
5 years ago
Pfizer IncPFE
1Hold$38.00N/AMaintains
5 years ago
Eli Lilly & CoLLY
2Hold$93.00N/AMaintains
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.